Altered aquaporin expression in women with polycystic ovary syndrome: Hyperandrogenism in follicular fluid inhibits aquaporin-9 in granulosa cells through the phosphatidylinositol 3-kinase pathway

Human Reproduction

Volumn 25, Issue 6, 2010, Pages 1441-1450

  Qu, Fan ^a   Wang, Fang Fang ^a   Lu, Xiu E ^a   Dong, Min Yue ^a   Sheng, Jian Zhong ^b   Lv, Ping Ping ^b   Ding, Guo Lian ^a   Shi, Bi Wei ^a   Zhang, Dan ^a   Huang, He Feng ^a,c  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Key Laboratory of Womens Reproductive Health of Zhejiang Province   (China)

Author keywords

Aquaporin 9; Granulosa cells; Hyperandrogenism; Polycystic ovary syndrome

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (HYDROXYMERCURI)BENZOIC ACID SODIUM SALT; ANDROGEN; ANDROSTANOLONE; AQUAPORIN 9; BENZOIC ACID DERIVATIVE; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; HYPOTONIC SOLUTION; LUTEINIZING HORMONE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; RECOMBINANT FOLLITROPIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; CELL MEMBRANE; CELL NUCLEUS; CELL SWELLING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; GRANULOSA CELL; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERANDROGENISM; IN VITRO STUDY; OVARY FOLLICLE FLUID; OVARY POLYCYSTIC DISEASE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TESTOSTERONE BLOOD LEVEL; UTERINE TUBE OCCLUSION; WESTERN BLOTTING;

EID: 77952804664     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deq078     Document Type: Article

References (33)

1. Agre P, Bonhivers M, Borgnia MJ. The aquaporins, blueprints for cellular plumbing systems. J Biol Chem 1998;273:14659-14662.
2. Bachtell NE, Conaghan J, Turek PJ. The relative viability of human spermatozoa from the vas deferens, epididymis and testis before and after cryopreservation. Hum Reprod 1999;14:3048-3051.
3. Das M, Djahanbakhch O, Hacihanefioglu B, Saridogan E, Ikram M, Ghali L, Raveendran M, Storey A. Granulosa cell survival and proliferation are altered in polycystic ovary syndrome. J Clin Endocrinol Metab 2008; 93:881-887.
4. Doi SA, Al-Zaid M, Towers PA, Scott CJ, Al-Shoumer KA. Steroidogenic alterations and adrenal androgen excess in PCOS. Steroids 2006; 71:751-759.
5. Escobar-Morreale HF, Asuncion M, Calvo RM, Sancho J, San Millan JL. Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies. Eur J Endocrinol 2001; 145:619-624.
6. Forges T, Gerard A, Hess K, Monnier-Barbarino P, Gerard H. Expression of sex hormone-binding globulin (SHBG) in human granulosa-lutein cells. Mol Cell Endocrinol 2004;219:61-68.
7. Franks S. Polycystic ovary syndrome. N Engl J Med 1995;333:853-861.
8. Gosden RG, Hunter RH, Telfer E, Torrance C, Brown N. Physiological factors underlying the formation of ovarian follicular fluid. J Reprod Fertil 1988;82:813-825.
9. Hirshfield AN. Development of follicles in the mammalian ovary. Int Rev Cytol 1991;124:43-101.
10. Huang HF, He RH, Sun CC, Zhang Y, Meng QX, Ma YY. Function of aquaporins in female and male reproductive systems. Hum Reprod Update 2006;12:785-795.
11. Jablonski EM, Webb AN, McConnell NA, Riley MC, Hughes FM Jr. Plasma membrane aquaporin activity can affect the rate of apoptosis but is inhibited after apoptotic volume decrease. Am J Physiol Cell Physiol 2004;286:C975-C985.
12. King LS, Agre P. Pathophysiology of the aquaporin water channels. Annu Rev Physiol 1996;58:619-648.
13. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078-3082.
14. Koskinen P, Penttila TA, Anttila L, Erkkola R, Irjala K. Optimal use of hormone determinations in the biochemical diagnosis of the polycystic ovary syndrome. Fertil Steril 1996;65:517-522.
15. Kumar A, Woods KS, Bartolucci AA, Azziz R. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 2005;62:644-649.
16. Ledee-Bataille N, Lapree-Delage G, Taupin JL, Dubanchet S, Taieb J, Moreau JF, Chaouat G. Follicular fluid concentration of leukaemia inhibitory factor is decreased among women with polycystic ovarian syndrome during assisted reproduction cycles. Hum Reprod 2001; 16:2073-2078.
17. Loughlin T, Cunningham S, Moore A, Culliton M, Smyth PP, McKenna TJ. Adrenal abnormalities in polycystic ovary syndrome. J Clin Endocrinol Metab 1986;62:142-147.
18. Martin B, Rotten D, Jolivet A, Gautray JP. Binding of steroids by proteins in follicular fluid of the human ovary. J Clin Endocrinol Metab 1981; 53:443-447.
19. Mason HD, Willis DS, Beard RW, Winston RM, Margara R, Franks S. Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid. J Clin Endocrinol Metab 1994;79:1355-1360.
20. McConnell NA, Yunus RS, Gross SA, Bost KL, Clemens MG, Hughes FM Jr. Water permeability of an ovarian antral follicle is predominantly transcellular and mediated by aquaporins. Endocrinology 2002; 143:2905-2912.
21. Nelson VL, Qin KN, Rosenfield RL, Wood JR, Penning TM, Legro RS, Strauss JF 3rd, McAllister JM. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2001;86:5925-5933.
22. Nikolettos N, Kupker W, Al-Hasani S, Demirel LC, Schopper B, Sturm R, Diedrich K. ICSI outcome in patients of 40 years age and over: a retrospective analysis. Eur J Obstet Gynecol Reprod Biol 2000; 91:177-182.
23. Onalan G, Selam B, Baran Y, Cincik M, Onalan R, Gunduz U, Ural AU, Pabuccu R. Serum and follicular fluid levels of soluble Fas, soluble Fas ligand and apoptosis of luteinized granulosa cells in PCOS patients undergoing IVF. Hum Reprod 2005;20:2391-2395.
24. Pastor-Soler N, Isnard-Bagnis C, Herak-Kramberger C, Sabolic I, Van Hoek A, Brown D, Breton S. Expression of aquaporin 9 in the adult rat epididymal epithelium is modulated by androgens. Biol Reprod 2002;66:1716-1722.
25. Preston GM, Carroll TP, Guggino WB, Agre P. Appearance of water channels in Xenopus oocytes expressing red cell CHIP28 protein. Science 1992;256:385-387.
26. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19:41-47.
27. Roberts R, Stark J, Iatropoulou A, Becker DL, Franks S, Hardy K. Energy substrate metabolism of mouse cumulus-oocyte complexes: response to follicle-stimulating hormone is mediated by the phosphatidylinositol 3-kinase pathway and is associated with oocyte maturation. Biol Reprod 2004;71:199-209.
28. Sayasith K, Bouchard N, Dore M, Sirois J. Regulation of bovine tumor necrosis factor alpha induced protein 6 in ovarian follicles during the ovulatory process and promoter activation in granulosa cells. Endocrinology 2008;149:6213-6225.
29. Sir-Petermann T, Codner E, Maliqueo M, Echiburu B, Hitschfeld C, Crisosto N, Perez-Bravo F, Recabarren SE, Cassorla F. Increased anti-Mullerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:3105-3109.
30. Stubbs SA, Stark J, Dilworth SM, Franks S, Hardy K. Abnormal preantral folliculogenesis in polycystic ovaries is associated with increased granulosa cell division. J Clin Endocrinol Metab 2007;92:4418-4426.
31. Volpe A, Coukos G, D'Ambrogio G, Artini PG, Genazzani AR. Follicular fluid steroid and epidermal growth factor content, and in vitro estrogen release by granulosa-luteal cells from patients with polycystic ovaries in an IVF/ET program. Eur J Obstet Gynecol Reprod Biol 1991; 42:195-199.
32. Wang J, Tanji N, Sasaki T, Kikugawa T, Song X, Yokoyama M. Androgens upregulate aquaporin 9 expression in the prostate. Int J Urol 2008; 15:936-941.
33. Wu YT, Tang L, Cai J, Lu XE, Xu J, Zhu XM, Luo Q, Huang HF. High bone morphogenetic protein-15 level in follicular fluid is associated with high quality oocyte and subsequent embryonic development. Hum Reprod 2007;22:1526-1531.